Weight Loss Genetic Disease
Food drug administration fda has approved imcivree setmelanotide for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin pomc proprotein.
Weight loss genetic disease. Biopharmaceutical company rhythm pharmaceuticals inc. The firm stated that in phase 3 clinical trials 80 of patients with obesity due to pomc or pcsk1 deficiency achieved greater than 10 weight loss and 45 5 of patients with obesity due to. Rytm nasdaq which is focused on developing treatments for rare genetic obesity diseases today announced that the u s.
Studies of genetic causes of severe obesity and resistance to obesity can help identify mechanisms of weight regulation and suggest targets for obesity therapies according to a speaker at.
Source : pinterest.com